Phreesia, Inc. $PHR Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC lowered its position in Phreesia, Inc. (NYSE:PHR) by 9.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 459,047 shares of the company’s stock after selling 46,321 shares during the quarter. Riverbridge Partners LLC owned approximately 0.76% of Phreesia worth $7,767,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Federated Hermes Inc. acquired a new stake in shares of Phreesia in the 3rd quarter valued at $32,000. Asset Management One Co. Ltd. acquired a new position in shares of Phreesia during the third quarter worth $45,000. State of Alaska Department of Revenue acquired a new position in shares of Phreesia during the third quarter worth $83,000. Anchor Investment Management LLC purchased a new position in Phreesia in the third quarter valued at $118,000. Finally, Smartleaf Asset Management LLC raised its stake in Phreesia by 129.0% in the third quarter. Smartleaf Asset Management LLC now owns 6,449 shares of the company’s stock valued at $152,000 after buying an additional 3,633 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

Insider Activity at Phreesia

In other news, insider David Linetsky sold 6,106 shares of Phreesia stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total value of $103,863.06. Following the transaction, the insider directly owned 231,723 shares of the company’s stock, valued at $3,941,608.23. The trade was a 2.57% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Balaji Gandhi sold 8,009 shares of the company’s stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $136,233.09. Following the completion of the sale, the chief financial officer owned 156,231 shares of the company’s stock, valued at approximately $2,657,489.31. This trade represents a 4.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 66,529 shares of company stock valued at $1,080,454 over the last 90 days. 5.50% of the stock is owned by insiders.

Phreesia Stock Performance

NYSE PHR opened at $11.64 on Friday. The company has a fifty day moving average of $12.72 and a two-hundred day moving average of $18.00. The company has a market capitalization of $701.44 million, a PE ratio of -116.34 and a beta of 0.67. Phreesia, Inc. has a 1 year low of $10.75 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Truist Financial set a $24.00 price target on Phreesia in a report on Thursday, January 8th. Wells Fargo & Company dropped their price objective on Phreesia from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday. JPMorgan Chase & Co. cut their target price on Phreesia from $29.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 20th. Needham & Company LLC reaffirmed a “buy” rating and issued a $35.00 price target on shares of Phreesia in a report on Monday, December 8th. Finally, Barclays dropped their price target on shares of Phreesia from $26.00 to $24.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 16th. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $28.65.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.